128 related articles for article (PubMed ID: 8739454)
1. Intravenous immunoglobulin in women with five or more abortions.
Carp HJ; Ahiron R; Mashiach S; Schonfeld Y; Gazit E; Toder V
Am J Reprod Immunol; 1996 Apr; 35(4):360-2. PubMed ID: 8739454
[TBL] [Abstract][Full Text] [Related]
2. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis.
Carp HJ; Toder V; Gazit E; Ahiron R; Torchinski A; Mashiach S; Shoenfeld Y
Am J Reprod Immunol; 2001 Oct; 46(4):268-73. PubMed ID: 11642675
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
Coulam CB; Krysa L; Stern JJ; Bustillo M
Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of anti-paternal antibodies and leukocyte immunizations on the proportion of live births in couples with consecutive recurrent miscarriages.
Orgad S; Loewenthal R; Gazit E; Sadetzki S; Novikov I; Carp H
Hum Reprod; 1999 Dec; 14(12):2974-9. PubMed ID: 10601081
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin.
Christiansen OB; Mathiesen O; Husth M; Rasmussen KL; Ingerslev HJ; Lauritsen JG; Grunnet N
Hum Reprod; 1995 Oct; 10(10):2690-5. PubMed ID: 8567794
[TBL] [Abstract][Full Text] [Related]
6. Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group.
Carp HJ; Toder V; Torchinsky A; Portuguese S; Lipitz S; Gazit E; Mashiach S
Hum Reprod; 1997 Feb; 12(2):250-5. PubMed ID: 9070705
[TBL] [Abstract][Full Text] [Related]
7. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
[TBL] [Abstract][Full Text] [Related]
8. Overcoming recurrent spontaneous abortions in women suffering from IgG subclass deficiency: high efficiency of low dose intravenous immunoglobulins treatment.
Manfredi G; Dell'Aera L; Liguori R
Eur Ann Allergy Clin Immunol; 2015 May; 47(3):91-4. PubMed ID: 25951147
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
Dendrinos S; Sakkas E; Makrakis E
Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage.
Ata B; Tan SL; Shehata F; Holzer H; Buckett W
Fertil Steril; 2011 Mar; 95(3):1080-5.e1-2. PubMed ID: 21232738
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experiences with passive immunotherapy in habitual abortion].
Heilmann L; Kriechbaum A; Hojnacki B; Bode V; Wolf H
Z Geburtshilfe Perinatol; 1993; 197(2):55-8. PubMed ID: 8204118
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment of women with multiple miscarriages.
Christiansen OB; Mathiesen O; Lauritsen JG; Grunnet N
Hum Reprod; 1992 May; 7(5):718-22. PubMed ID: 1639992
[TBL] [Abstract][Full Text] [Related]
13. [Application of intravenous immunoglobulin therapy (IVIG) in pregnant patients with recurrent spontaneous abortions].
Sipak-Szmigiel O; Ronin-Walknowska E; Mikłaszwicz A
Ginekol Pol; 2003 May; 74(5):350-5. PubMed ID: 12931461
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin treatment of pregnant patients with unexplained recurrent abortions.
Raziel A; Herman A; Bukovsky I; Caspi E; Ron-el R
Hum Reprod; 1996 Apr; 11(4):711-5. PubMed ID: 8671312
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
[TBL] [Abstract][Full Text] [Related]
16. Live birth rate varies with gestational history and etiology in women experiencing recurrent spontaneous abortion.
Morikawa M; Yamada H; Kato EH; Shimada S; Sakuragi N; Fujimoto S; Minakami H
Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):21-6. PubMed ID: 12818438
[TBL] [Abstract][Full Text] [Related]
17. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin.
Marzusch K; Dietl J; Klein R; Hornung D; Neuer A; Berg PA
Acta Obstet Gynecol Scand; 1996 Nov; 75(10):922-6. PubMed ID: 9003094
[TBL] [Abstract][Full Text] [Related]
18. [The management of unexplained recurrent abortions. Is immunotherapy an option?].
Constantinescu D; Cozmei C; Dumitraşcu I; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):371-8. PubMed ID: 19295006
[TBL] [Abstract][Full Text] [Related]
19. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities.
Kiprov DD; Nachtigall RD; Weaver RC; Jacobson A; Main EK; Garovoy MR
Am J Reprod Immunol; 1996 Oct; 36(4):228-34. PubMed ID: 8911631
[TBL] [Abstract][Full Text] [Related]
20. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.
Hutton B; Sharma R; Fergusson D; Tinmouth A; Hebert P; Jamieson J; Walker M
BJOG; 2007 Feb; 114(2):134-42. PubMed ID: 17166218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
